214 related articles for article (PubMed ID: 17202325)
1. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
[TBL] [Abstract][Full Text] [Related]
2. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.
Koppers-Lalic D; Reits EA; Ressing ME; Lipinska AD; Abele R; Koch J; Marcondes Rezende M; Admiraal P; van Leeuwen D; Bienkowska-Szewczyk K; Mettenleiter TC; Rijsewijk FA; Tampé R; Neefjes J; Wiertz EJ
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5144-9. PubMed ID: 15793001
[TBL] [Abstract][Full Text] [Related]
3. The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex.
Verweij MC; Koppers-Lalic D; Loch S; Klauschies F; de la Salle H; Quinten E; Lehner PJ; Mulder A; Knittler MR; Tampé R; Koch J; Ressing ME; Wiertz EJ
J Immunol; 2008 Oct; 181(7):4894-907. PubMed ID: 18802093
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
Verweij MC; Ressing ME; Knetsch W; Quinten E; Halenius A; van Bel N; Hengel H; Drijfhout JW; van Hall T; Wiertz EJ
Mol Immunol; 2011 Mar; 48(6-7):835-45. PubMed ID: 21292324
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T cell responses against TAP-inhibited cells are readily detected in the human population.
Lampen MH; Verweij MC; Querido B; van der Burg SH; Wiertz EJ; van Hall T
J Immunol; 2010 Dec; 185(11):6508-17. PubMed ID: 20980626
[TBL] [Abstract][Full Text] [Related]
6. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
[TBL] [Abstract][Full Text] [Related]
7. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
[TBL] [Abstract][Full Text] [Related]
8. The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus.
Verweij MC; Lipinska AD; Koppers-Lalic D; van Leeuwen WF; Cohen JI; Kinchington PR; Messaoudi I; Bienkowska-Szewczyk K; Ressing ME; Rijsewijk FA; Wiertz EJ
J Virol; 2011 Mar; 85(5):2351-63. PubMed ID: 21159875
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of the TAP-inhibiting UL49.5 proteins of varicelloviruses.
Verweij MC; Lipińska AD; Koppers-Lalic D; Quinten E; Funke J; van Leeuwen HC; Bieńkowska-Szewczyk K; Koch J; Ressing ME; Wiertz EJ
Mol Immunol; 2011 Sep; 48(15-16):2038-51. PubMed ID: 21764135
[TBL] [Abstract][Full Text] [Related]
10. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
[TBL] [Abstract][Full Text] [Related]
11. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
[TBL] [Abstract][Full Text] [Related]
13. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
[TBL] [Abstract][Full Text] [Related]
14. TAP-independent presentation of CTL epitopes by Trojan antigens.
Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
[TBL] [Abstract][Full Text] [Related]
15. Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL.
Durgeau A; El Hage F; Vergnon I; Validire P; de Montpréville V; Besse B; Soria JC; van Hall T; Mami-Chouaib F
J Immunol; 2011 Dec; 187(11):5532-9. PubMed ID: 22025554
[TBL] [Abstract][Full Text] [Related]
16. Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8
Abdulhaqq SA; Wu H; Schell JB; Hammond KB; Reed JS; Legasse AW; Axthelm MK; Park BS; Asokan A; Früh K; Hansen SG; Picker LJ; Sacha JB
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315990
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on TAP and its vital role in antigen presentation and cross-presentation.
Mantel I; Sadiq BA; Blander JM
Mol Immunol; 2022 Feb; 142():105-119. PubMed ID: 34973498
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.
Andersen MH; Bonfill JE; Neisig A; Arsequell G; Sondergaard I; Valencia G; Neefjes J; Zeuthen J; Elliott T; Haurum JS
J Immunol; 1999 Oct; 163(7):3812-8. PubMed ID: 10490979
[TBL] [Abstract][Full Text] [Related]
19. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
20. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
Doorduijn EM; Sluijter M; Querido BJ; Oliveira CC; Achour A; Ossendorp F; van der Burg SH; van Hall T
J Clin Invest; 2016 Feb; 126(2):784-94. PubMed ID: 26784543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]